XLV
Health Care Select Sector SPDR FundPrevious close
171.99
Change
+0.69%
Expense ratio
0.08%
AUM
$44.2B
Holdings
64
100% look-through
YTD
+11.1%
1Y
+21.0%
5Y
+34.4%
Returns
Price return, excluding dividends| 1M | 3M | YTD | 1Y | 3Y | 5Y | |
|---|---|---|---|---|---|---|
| XLV | +4.0% | +6.6% | +11.1% | +21.0% | +32.1% | +34.4% |
| SPY | +1.8% | +3.9% | +14.1% | +19.2% | +80.3% | +74.5% |
| Difference | +2.2% | +2.7% | −3.0% | +1.9% | −48.2% | −40.1% |
| Ticker | Company | Weight |
|---|---|---|
| LLY | Lilly (Eli) | 15.13% |
| JNJ | Johnson & Johnson | 10.17% |
| ABBV | AbbVie | 7.95% |
| MRK | Merck & Co. | 5.74% |
| UNH | UnitedHealth Group | 5.43% |
| TMO | Thermo Fisher Scientific | 3.92% |
| AMGN | Amgen | 3.61% |
| GILD | Gilead Sciences | 2.98% |
| ABT | Abbott Laboratories | 2.82% |
| PFE | Pfizer | 2.59% |
| ISRG | Intuitive Surgical | 2.42% |
| DHR | Danaher Corporation | 2.21% |
| VRTX | Vertex Pharmaceuticals | 2.06% |
| MDT | Medtronic | 1.88% |
| BMY | Bristol Myers Squibb | 1.88% |
| CVS | CVS Health | 1.79% |
| MCK | McKesson Corporation | 1.78% |
| SYK | Stryker Corporation | 1.58% |
| ELV | Elevance Health | 1.46% |
| MRNA | Moderna | 1.27% |
| CI | Cigna | 1.20% |
| REGN | Regeneron Pharmaceuticals | 1.20% |
| HCA | HCA Healthcare | 1.08% |
| BSX | Boston Scientific | 1.02% |
| COR | Cencora | 0.99% |
Look-through checkup
Valuation, growth and FinDog views of the holdings, weighted by position; covers 100% of the fund5-year valuation percentile
47
Where each company's P/E sits in its own 5-year range, weighted
Revenue growth (YoY)
+14.6%
Position-weighted
Gross margin
69.1%
Position-weighted
Holdings dividend yield
1.89%
Position-weighted
Reported
67%
67% of look-through weight
EPS beat
68%
of reported weight
EPS miss
26%
of reported weight
Guidance raised
0.0%
Guidance cut
1.7%
Top holdings that have reported